Randox Laboratories has been appointed to the National Framework Agreement for the Provision of Biomedical and Clinical Research Support, established by the Countess of Chester Hospital NHS Foundation Trust. The framework enables public sector organisations across the UK to access specialist services that support biomedical and clinical research programmes.
Covering the full research lifecycle, the framework includes logistics, sample processing, storage, data management and laboratory support services. Through its appointment, Randox will provide its expertise in diagnostic technologies, laboratory services and clinical research support to help organisations efficiently deliver research studies and clinical trials.
Lindsey Munnoch, Head of Key Accounts, Randox Laboratories, commented: "We are delighted to be appointed to this important national framework. Research and innovation are fundamental to improving patient outcomes and advancing healthcare delivery. Through our laboratory capabilities, innovative technologies and experienced scientific teams, Randox is committed to supporting public sector organisations in delivering high-quality biomedical and clinical research programmes that make a meaningful impact on patient care."
As a global leader in diagnostics and healthcare innovation, Randox continues to invest in technologies and services that support precision medicine, clinical trials and population health initiatives.
More information on the framework can be accessed by clicking here.